000 01266 a2200361 4500
005 20250512074511.0
264 0 _c19850627
008 198506s 0 0 eng d
022 _a0344-5704
024 7 _a10.1007/BF00258115
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHill, B T
245 0 0 _aIdentification of anthracycline analogues with enhanced cytotoxicity and lack of cross-resistance to adriamycin using a series of mammalian cell lines in vitro.
_h[electronic resource]
260 _bCancer chemotherapy and pharmacology
_c1985
300 _a194-201 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aAntibiotics, Antineoplastic
_xpharmacology
650 0 4 _aCell Line
650 0 4 _aColony-Forming Units Assay
650 0 4 _aCricetinae
650 0 4 _aDoxorubicin
_xpharmacology
650 0 4 _aDrug Resistance
650 0 4 _aHumans
650 0 4 _aMesocricetus
650 0 4 _aNaphthacenes
_xpharmacology
650 0 4 _aTumor Stem Cell Assay
700 1 _aDennis, L Y
700 1 _aLi, X T
700 1 _aWhelan, R D
773 0 _tCancer chemotherapy and pharmacology
_gvol. 14
_gno. 3
_gp. 194-201
856 4 0 _uhttps://doi.org/10.1007/BF00258115
_zAvailable from publisher's website
999 _c3863706
_d3863706